Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America
Compelling New Patient Outcome Data to be Presented
Oak Ridge, TN, Sept. 26, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq:DXR), the global leader in blood volume measurement technology, today announces it will be attending the Annual Scientific Meeting of the Heart Failure Society of America (HFSA) which brings together the world’s leading experts in heart failure at the Gaylord National Harbor in Washington, DC from September 30th thru October 3rd, 2022.
Related news for (DXR)
- Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
- 24/7 Market News Snapshot 07 August, 2025 – Daxor Corporation Common Stock (NASDAQ:DXR)
- Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
- Daxor’s Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
- Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology